- $38.59m
- $7.67m
- $18.24m
- 60
- 39
- 74
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.2 | 11.3 | 16.9 | 16 | 18.2 |
Cost of Revenue | |||||
Gross Profit | 10.9 | 10.5 | 15.6 | 14.7 | 17 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.3 | 20.7 | 23 | 18.2 | 26.8 |
Operating Profit | -4.13 | -9.42 | -6.1 | -2.22 | -8.54 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.13 | -9.25 | -6.09 | -1.68 | -7.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.34 | -7.61 | -5.82 | -1.73 | -7.31 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.34 | -7.61 | -5.82 | -1.73 | -7.31 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.34 | -7.61 | -5.82 | -1.73 | -7.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.387 | -0.355 | -0.271 | -0.251 | -0.265 |